Background: Serum cardiac troponin I (cTnI) is a specific marker of myocardial injury related to in-patient fatality and cardiac injury in acute stroke. We investigated whether cTnI in acute stroke is related to serum cortisol, acute inflammatory response, and insular damage. We also investigated whether cTnI predicted outcome at 3 months. Patients and Methods: The study was based on 155 patients with CT-confirmed acute cerebral infarction and study inclusion within 24 h (50% within 12 h) of stroke onset. Blood samples were obtained on inclusion. Stroke severity was assessed by the Scandinavian Stroke Scale (SSS) and outcome was assessed by the modified Rankin Scale (mRS), death or dependency was defined as mRS ≧3 three months after stroke. Results: 35% of all patients and 63% of patients who died within 3 months were troponin positive. Tumor necrosis factor-α (TNF-α) and cortisol were independently related to detection of cTnI: TNF-α+100 pg/ml OR 1.5 (CI 95% 1.1–2.2), cortisol+100 nmol/l OR 1.1 (CI 95% 1.01–1.2). SSS and age were also included in this model and did not reach significance. cTnI positivity was, together with age, stroke severity and prestroke mRS, but not s-cortisol, an independent explanatory variable of outcome at 3 months (death or dependency) with OR 4.1 (CI 95% 1.1–14.5). cTnI did not relate to insular involvement. Conclusion: In this study, cortisol and TNF-α were independently related to cTnI, which was predictive of 3-month prognosis.

1.
Apple FS: Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB. Clin Chim Acta 1999;284:151–159.
2.
Hamm CW, Braunwald E: A classification of unstable angina revisited. Circulation 2000;102:118–122.
3.
Hamm CW, Giannitsis E, Katus HA: Cardiac troponin elevations in patients without acute coronary syndrome. Circulation 2002;106:2871–2872.
4.
Kaste M, Somer H, Konttinen A: Heart type creatinine isoenzyme (CKMB) in acute cerebral disorders. Br Heart J 1978;40:802–805.
5.
James P, Ellis CJ, Whitlock RML, McNeil AR, Henley J, Anderson NE: Relation between troponin T concentration and mortality in patients presenting with an acute stroke: Observational study. BMJ 2000;320:1502–1504.
6.
Troøyen M, Indredavik B, Rossvoll O, Slørdahl SA: The use of cardiac troponin I to determine the incidence of myocardial injury in patients with acute stroke (in Norwegian). Tidsskr Nor Lægeforen 2001;121:421–425.
7.
Oppenheimer SM, Cechetto DF, Hachinski VC: Cerebrogenic cardiac arrythmias. Cerebral electrocardiographic influences and their role in sudden death. Arch Neurol 1990;47:513–519.
8.
Myers MS, Noris JW, Hachinski VC, Weingert ME, Sole MJ: Cardiac sequelae of acute stroke. Stroke 1982;13:838–842.
9.
Meldrum DR: Tumor necrosis factor in the heart. Am J Physiol 1998;274:R557–R595.
10.
Christensen H, Boysen G, Christensen E, Johannesen HH, Bendtzen K: Plasma cytokines in acute stroke. J Stroke Cerebrovasc Dis 2002;11:72–79.
11.
Christensen H, Boysen G, Christensen E, Johannesen HH, Bendtzen K: Deteriorating ischaemic stroke: Cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke. J Neurol Sci 2002;201:1–7.
12.
Sairanen T, Carpén O, Karjalainen-Lindsberg M-L, Paetau A, Turpeinen U, Kaste M, et al: Evolution of cerebral tumor necrosis factor-α production during human ischemic stroke. Stroke 2001;32:1750–1758.
13.
Zaremba J, Losy J: Early TNF-α levels correlate with ischaemic stroke severity. Acta Neurol Scand 2001;104:288–295.
14.
Cheung RTF, Hachinski VC: The insula and sudden cerebrogenic death. Arch Neurol 2000;57:1685–1688.
15.
Lindenstrøm E, Boysen G, Christiansen LW, à Rogvi Hansen B, Nielsen PW: Reliability of Scandinavian Neurological Stroke Scale. Cerebrovasc Dis 1991;1:103–107.
16.
van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604–607.
17.
van der Worp HB, Claus SP, Bär PR, Ramos LMP, Algra A, van Gijn J, et al: Reproducibility of measurements of cerebral infarct volume on CT scans. Stroke 2001;32:424–428.
18.
Franceschini R, Gandolfo C, Cataldi A, Del Sette M, Cianciosi P, Finocchi C, et al: Twenty-four-hour β-endorphin secretory pattern in stroke patients. Stroke 1994;25:2142–2145.
19.
Christensen H, Boysen G: Blood glucose increased early after stroke onset. A study on serial measurements. Eur J Neurol 2002;9:297–301.
20.
Sandøe E, Sigurd B: Arrhythmia: A Clinical Electrocardiographic Guide. Bingen, Publishing Partners Verlag, 1991.
21.
Ay H, Arsava EM, Saribas O: Creatine kinase-MB elevation after stroke is not cardiac in origin: Comparison with troponin T levels. Stroke 2002;33:286–289.
22.
Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E, et al: Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003;41:2004–2009.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.